209 related articles for article (PubMed ID: 32295565)
1. Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2).
Husain MI; Cullen C; Umer M; Carvalho AF; Kloiber S; Meyer JH; Ortiz A; Knyahnytska Y; Husain MO; Giddens J; Diniz BS; Wang W; Young AH; Mulsant BH; Daskalakis ZJ
BMC Psychiatry; 2020 Apr; 20(1):173. PubMed ID: 32295565
[TBL] [Abstract][Full Text] [Related]
2. Minocycline as an adjunct for treatment-resistant depressive symptoms: A pilot randomised placebo-controlled trial.
Husain MI; Chaudhry IB; Husain N; Khoso AB; Rahman RR; Hamirani MM; Hodsoll J; Qurashi I; Deakin JF; Young AH
J Psychopharmacol; 2017 Sep; 31(9):1166-1175. PubMed ID: 28857658
[TBL] [Abstract][Full Text] [Related]
3. Minocycline as an adjunct for treatment-resistant depressive symptoms: study protocol for a pilot randomised controlled trial.
Husain MI; Chaudhry IB; Rahman RR; Hamirani MM; Qurashi I; Khoso AB; Deakin JF; Husain N; Young AH
Trials; 2015 Sep; 16():410. PubMed ID: 26374703
[TBL] [Abstract][Full Text] [Related]
4. Effect of Minocycline on Depressive Symptoms in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.
Hellmann-Regen J; Clemens V; Grözinger M; Kornhuber J; Reif A; Prvulovic D; Goya-Maldonado R; Wiltfang J; Gruber O; Schüle C; Padberg F; Ising M; Uhr M; Friede T; Huber C; Manook A; Baghai TC; Rupprecht R; Heuser I
JAMA Netw Open; 2022 Sep; 5(9):e2230367. PubMed ID: 36103181
[TBL] [Abstract][Full Text] [Related]
5. Adjunctive minocycline treatment for major depressive disorder: A proof of concept trial.
Dean OM; Kanchanatawan B; Ashton M; Mohebbi M; Ng CH; Maes M; Berk L; Sughondhabirom A; Tangwongchai S; Singh AB; McKenzie H; Smith DJ; Malhi GS; Dowling N; Berk M
Aust N Z J Psychiatry; 2017 Aug; 51(8):829-840. PubMed ID: 28578592
[TBL] [Abstract][Full Text] [Related]
6. Effect of Adjunctive Simvastatin on Depressive Symptoms Among Adults With Treatment-Resistant Depression: A Randomized Clinical Trial.
Husain MI; Chaudhry IB; Khoso AB; Kiran T; Khan N; Ahmad F; Hodsoll J; Husain MO; Naqvi HA; Nizami AT; Chaudhry N; Khan HA; Minhas F; Meyer JH; Ansari MA; Mulsant BH; Husain N; Young AH
JAMA Netw Open; 2023 Feb; 6(2):e230147. PubMed ID: 36808239
[TBL] [Abstract][Full Text] [Related]
7. N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double-blind randomized placebo-controlled trial.
Yang C; Bosker FJ; Li J; Schoevers RA
BMC Psychiatry; 2018 Sep; 18(1):279. PubMed ID: 30176835
[TBL] [Abstract][Full Text] [Related]
8. Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial.
Husain MI; Chaudhry IB; Khoso AB; Husain MO; Hodsoll J; Ansari MA; Naqvi HA; Minhas FA; Carvalho AF; Meyer JH; Deakin B; Mulsant BH; Husain N; Young AH
Lancet Psychiatry; 2020 Jun; 7(6):515-527. PubMed ID: 32445690
[TBL] [Abstract][Full Text] [Related]
9. Minocycline as adjunctive treatment for major depressive disorder: Pooled data from two randomized controlled trials.
Zazula R; Husain MI; Mohebbi M; Walker AJ; Chaudhry IB; Khoso AB; Ashton MM; Agustini B; Husain N; Deakin J; Young AH; Berk M; Kanchanatawan B; Ng CH; Maes M; Berk L; Singh AB; Malhi GS; Dean OM
Aust N Z J Psychiatry; 2021 Aug; 55(8):784-798. PubMed ID: 33092404
[TBL] [Abstract][Full Text] [Related]
10. Adjunctive simvastatin for treatment-resistant depression: study protocol of a 12-week randomised controlled trial.
Husain MI; Chaudhry IB; Khoso AB; Husain MO; Rahman RR; Hamirani MM; Hodsoll J; Carvalho AF; Husain N; Young AH
BJPsych Open; 2019 Jan; 5(1):e13. PubMed ID: 30762508
[TBL] [Abstract][Full Text] [Related]
11. A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression.
Barbee JG; Thompson TR; Jamhour NJ; Stewart JW; Conrad EJ; Reimherr FW; Thompson PM; Shelton RC
J Clin Psychiatry; 2011 Oct; 72(10):1405-12. PubMed ID: 21367355
[TBL] [Abstract][Full Text] [Related]
12. Sex differences in a double-blind randomized clinical trial with minocycline in treatment-resistant depressed patients: CRP and IL-6 as sex-specific predictors of treatment response.
Lombardo G; Nettis MA; Hastings C; Zajkowska Z; Mariani N; Nikkheslat N; Worrell C; Enache D; McLaughlin A; Kose M; Bogdanova A; Sforzini L; Cleare AJ; Young AH; Dazzan P; Mondelli V; Pariante CM
Brain Behav Immun Health; 2022 Dec; 26():100561. PubMed ID: 36467125
[TBL] [Abstract][Full Text] [Related]
13. Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.
Berman RM; Fava M; Thase ME; Trivedi MH; Swanink R; McQuade RD; Carson WH; Adson D; Taylor L; Hazel J; Marcus RN
CNS Spectr; 2009 Apr; 14(4):197-206. PubMed ID: 19407731
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trial.
McAllister-Williams RH; Anderson IM; Finkelmeyer A; Gallagher P; Grunze HC; Haddad PM; Hughes T; Lloyd AJ; Mamasoula C; McColl E; Pearce S; Siddiqi N; Sinha BN; Steen N; Wainwright J; Winter FH; Ferrier IN; Watson S;
Lancet Psychiatry; 2016 Feb; 3(2):117-27. PubMed ID: 26727041
[TBL] [Abstract][Full Text] [Related]
15. Acceptability, Tolerability, and Estimates of Putative Treatment Effects of Probiotics as Adjunctive Treatment in Patients With Depression: A Randomized Clinical Trial.
Nikolova VL; Cleare AJ; Young AH; Stone JM
JAMA Psychiatry; 2023 Aug; 80(8):842-847. PubMed ID: 37314797
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression: A Randomized Clinical Trial.
Quiroz JA; Tamburri P; Deptula D; Banken L; Beyer U; Rabbia M; Parkar N; Fontoura P; Santarelli L
JAMA Psychiatry; 2016 Jul; 73(7):675-84. PubMed ID: 27304433
[TBL] [Abstract][Full Text] [Related]
17. Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study.
Sanacora G; Johnson MR; Khan A; Atkinson SD; Riesenberg RR; Schronen JP; Burke MA; Zajecka JM; Barra L; Su HL; Posener JA; Bui KH; Quirk MC; Piser TM; Mathew SJ; Pathak S
Neuropsychopharmacology; 2017 Mar; 42(4):844-853. PubMed ID: 27681442
[TBL] [Abstract][Full Text] [Related]
18. A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Design Trial of Adjunctive Riluzole for Treatment-Resistant Major Depressive Disorder.
Mathew SJ; Gueorguieva R; Brandt C; Fava M; Sanacora G
Neuropsychopharmacology; 2017 Dec; 42(13):2567-2574. PubMed ID: 28553836
[TBL] [Abstract][Full Text] [Related]
19. Minocycline as adjunctive therapy for patients with unipolar psychotic depression: an open-label study.
Miyaoka T; Wake R; Furuya M; Liaury K; Ieda M; Kawakami K; Tsuchie K; Taki M; Ishihara K; Araki T; Horiguchi J
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jun; 37(2):222-6. PubMed ID: 22349578
[TBL] [Abstract][Full Text] [Related]
20. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
Griebel G; Beeské S; Stahl SM
J Clin Psychiatry; 2012 Nov; 73(11):1403-11. PubMed ID: 23146246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
